Cancer immunotherapy: are we there yet?

por Li, Zihai, Chen, Lieping, Rubinstein, Mark P
Publicado 2013

Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing

por Li, Zihai, Song, Wenru, Rubinstein, Mark, Liu, Delong
Publicado 2018

What's new in IL-12? Combination!

por Lawrence, Chris E, Rubinstein, Mark, Gluzman-Poltorak, Zoya, Vainstein, Vladimir, Basile, Lena A
Publicado 2015

Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model

por Janakiraman, Harinarayanan, Becker, Scott A., Bradshaw, Alexandra, Rubinstein, Mark P., Camp, Ernest Ramsay
Publicado 2022

Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy

por Bowers, Jacob S., Bailey, Stefanie R., Rubinstein, Mark P., Paulos, Chrystal M., Camp, E. Ramsay
Publicado 2019

IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness

por Johnson, C Bryce, May, Bennett R, Cloud, Colleen A, Rubinstein, Mark P, Cole, David J
Publicado 2013

Emerging Trends in Immunotherapy for Adult Sarcomas

por Husain, Marium, Chen, Luxi, Liebner, David, Beane, Joal, Rubinstein, Mark, Pollock, Raphael, Verschraegen, Claire, Tinoco, Gabriel
Publicado 2023

Antiviral CD4(+) memory T cells are IL-15 dependent

por Purton, Jared F., Tan, Joyce T., Rubinstein, Mark P., Kim, David M., Sprent, Jonathan, Surh, Charles D.
Publicado 2007

Exploration of the Effect of Tobacco Smoking on Metabolic Measures in Young People Living with HIV

por Rubinstein, Mark L., Harris, D. Robert, Rudy, Bret J., Kapogiannis, Bill G., Aldrovandi, Grace M., Mulligan, Kathleen
Publicado 2014

Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice

por Johnson, Christopher B, Riesenberg, Brian, Neitzke, Dan, Jeng, Emily K, Marcus, Warren D, Cole, David, Wong, Hing C, Rubinstein, Mark P
Publicado 2014

An intense form of homeostatic proliferation of naive CD8(+) cells driven by IL-2

por Cho, Jae-Ho, Boyman, Onur, Kim, Hee-Ok, Hahm, Bumsuk, Rubinstein, Mark P., Ramsey, Chris, Kim, David M., Surh, Charles D., Sprent, Jonathan
Publicado 2007

G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b(+)Gr-1(+) myeloid cells without compromising CD8(+) T cell immune responses

por Rubinstein, Mark P, Salem, Mohamed L, Doedens, Andrew L, Moore, Caitlin J, Chiuzan, Cody, Rivell, Guillermo L, Cole, David J, Goldrath, Ananda W
Publicado 2013

Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syng...

por Chen, Xiaoyue, Liu, Bai, Han, Kaiping, Kong, Lin, Noel, Terra, Jeng, Emily K, Alter, Sarah, Rubinstein, Mark, Rhode, Peter R, Wong, Hing C
Publicado 2015

Neural Correlates of Smartphone Dependence in Adolescents

por Tymofiyeva, Olga, Yuan, Justin P., Kidambi, Roma, Huang, Chiung-Yu, Henje, Eva, Rubinstein, Mark L., Jariwala, Namasvi, Max, Jeffrey E., Yang, Tony T., Xu, Duan
Publicado 2020

COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer

por Zeng, Cong, Evans, John P., Chakravarthy, Karthik, Qu, Panke, Reisinger, Sarah, Song, No-Joon, Rubinstein, Mark P., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2022

Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities

por Curran, Thomas, Sun, Zequn, Gerry, Brielle, Findlay, Victoria J., Wallace, Kristin, Li, Zihai, Paulos, Chrystal, Ford, Marvella, Rubinstein, Mark P., Chung, Dongjun, Camp, E. Ramsay
Publicado 2021

Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines

por Dwyer, Connor J., Knochelmann, Hannah M., Smith, Aubrey S., Wyatt, Megan M., Rangel Rivera, Guillermo O., Arhontoulis, Dimitrios C., Bartee, Eric, Li, Zihai, Rubinstein, Mark P., Paulos, Chrystal M.
Publicado 2019

Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8(+) T cells

por Dwyer, Connor J., Arhontoulis, Dimitrios C., Rangel Rivera, Guillermo O, Knochelmann, Hannah M., Smith, Aubrey S., Wyatt, Megan M., Rubinstein, Mark P., Atkinson, Carl, Thaxton, Jessica E., Neskey, David M., Paulos, Chrystal M.
Publicado 2020

Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients

por Zeng, Cong, Evans, John P., Reisinger, Sarah, Woyach, Jennifer, Liscynesky, Christina, Boghdadly, Zeinab El, Rubinstein, Mark P., Chakravarthy, Karthik, Saif, Linda, Oltz, Eugene M., Gumina, Richard J., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2021

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients

por Zeng, Cong, Evans, John P., Reisinger, Sarah, Woyach, Jennifer, Liscynesky, Christina, Boghdadly, Zeinab El, Rubinstein, Mark P., Chakravarthy, Karthik, Saif, Linda, Oltz, Eugene M., Gumina, Richard J., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2021